RedHill Biopharma Ltd. RDHL
NASDAQ
Recommendation
Dividend Power Score
Day's Range
$0.41$0.45
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
EPS (TTM)
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | 50.01% | 65.02% | 69.14% |
| Total Depreciation and Amortization | -- | -- | -72.86% | -62.76% | -55.16% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | 138.84% | -88.60% | -72.04% |
| Change in Net Operating Assets | -- | -- | -130.30% | 67.27% | 91.37% |
| Cash from Operations | -- | -- | 63.18% | -302.32% | 73.28% |
| Capital Expenditure | -- | -- | 55.56% | -14.29% | -140.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 55.56% | -1,700.00% | -220.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 70.28% | 63.33% | 58.90% |
| Issuance of Common Stock | -- | -- | -58.27% | -72.84% | -79.87% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 96.75% | -91.20% |
| Cash from Financing | -- | -- | -58.97% | -64.84% | -84.60% |
| Foreign Exchange rate Adjustments | -- | -- | 0.00% | 306.25% | 196.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | -76.51% | -128.77% | -1,669.75% |